Answers are grounded in this paper and cite their sources.
Randomized trial evaluates efficacy and safety of crisugabalin in patients with central neuropathic pain, indicating potential for pain management.
To evaluate the efficacy and safety of crisugabalin in patients with moderate-to-severe central neuropathic pain (cNP).
No takes yet. Share an insight, caveat, or question.
Fan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: